| Dr Lise D Brown, DO | |
|
800 W Boise Cir Ste 400, Broken Arrow, OK 74012-4974 | |
| (918) 307-0215 | |
| (918) 250-7669 |
| Full Name | Dr Lise D Brown |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 21 Years |
| Location | 800 W Boise Cir Ste 400, Broken Arrow, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306947163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | OS9720 (Florida) | Secondary |
| 207N00000X | Dermatology | 8224 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Cancer Specialists And Research Institute, Llc | 0042513558 | 50 |
News Archive
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs.
MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.
Maryland's top health official, Joshua M. Sharfstein, announced Wednesday that he will leave at the end of Gov. Martin O'Malley's term in January to become an associate dean at the Johns Hopkins Bloomberg School of Public Health (Johnson, 7/30).
› Verified 3 days ago
| Entity Name | Oklahoma Cancer Specialists And Research Institute, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104291236 PECOS PAC ID: 0042513558 Enrollment ID: O20160115001766 |
News Archive
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs.
MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.
Maryland's top health official, Joshua M. Sharfstein, announced Wednesday that he will leave at the end of Gov. Martin O'Malley's term in January to become an associate dean at the Johns Hopkins Bloomberg School of Public Health (Johnson, 7/30).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lise D Brown, DO 800 W Boise Cir Ste 400, Broken Arrow, OK 74012-4974 Ph: (918) 307-0215 | Dr Lise D Brown, DO 800 W Boise Cir Ste 400, Broken Arrow, OK 74012-4974 Ph: (918) 307-0215 |
News Archive
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs.
MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.
Maryland's top health official, Joshua M. Sharfstein, announced Wednesday that he will leave at the end of Gov. Martin O'Malley's term in January to become an associate dean at the Johns Hopkins Bloomberg School of Public Health (Johnson, 7/30).
› Verified 3 days ago
Dr. Carlos Gomez-meade, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 W. Boise Circle, Suite 400, Broken Arrow, OK 74012 Phone: 918-307-0215 Fax: 918-250-7669 | |
Dr. Janelle Marshall Pavlis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 W Boise Cir Ste 400, Broken Arrow, OK 74012 Phone: 918-307-0215 Fax: 918-250-7669 | |
Dr. Mary Melissa Morgan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1621 S Eucalyptus Ave, Suite 202, Broken Arrow, OK 74012 Phone: 918-459-7546 Fax: 918-459-7575 |